Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Non-cash Items: 2017-2024

Historic Non-cash Items for Dianthus Therapeutics (DNTH) over the last 5 years, with Dec 2024 value amounting to $24.9 million.

  • Dianthus Therapeutics' Non-cash Items rose 86.17% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 86.17%. This contributed to the annual value of $24.9 million for FY2024, which is 681.74% up from last year.
  • As of FY2024, Dianthus Therapeutics' Non-cash Items stood at $24.9 million, which was up 681.74% from $3.2 million recorded in FY2023.
  • In the past 5 years, Dianthus Therapeutics' Non-cash Items ranged from a high of $24.9 million in FY2024 and a low of $3.2 million during FY2023.
  • Moreover, its 3-year median value for Non-cash Items was $3.6 million (2022), whereas its average is $10.6 million.
  • Per our database at Business Quant, Dianthus Therapeutics' Non-cash Items dropped by 12.64% in 2023 and then spiked by 681.74% in 2024.
  • Over the past 3 years, Dianthus Therapeutics' Non-cash Items (Yearly) stood at $3.6 million in 2022, then decreased by 12.64% to $3.2 million in 2023, then skyrocketed by 681.74% to $24.9 million in 2024.